Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
Fort Lee, N.J., Aug. 15, 2023 — Elevar Therapeutics, Inc., majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced the hiring of Dr. Chris
